Deans' stroke musings: Scientists Develop Drug That Can 'Melt Away' Harmful Fat

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, November 4, 2017

Scientists Develop Drug That Can 'Melt Away' Harmful Fat - arterial plaque

Maybe in 50 years it might make it to clinical practice, but I doubt it.

https://www.yahoo.com/finance/news/scientists-develop-drug-apos-melt-182645220.html

Emily Price 9 hours ago

Scientists think they’ve discovered a new drug that can melt away heart-clogging fat.

CNBC reports that researchers from the University of Aberdeen think that one dose of a new drug Trodusquemine could completely reverse the effects of Atherosclerosis, the build-up of fatty plaque in the arteries. The condition can cause a number of heart problems, including a stroke or heart attack.

The drug was initially developed to help treat cancer and diabetes. Another cancer drug, Canakinumab, was recently discovered to have some heart benefits as well.
Researchers have found that mice that are given a single dose of the drug have less fatty plaque in their arteries than those that have not had the drug. It’s still in a pre-clinical level trial, but it seems to be working.

Next, researchers plan to conduct human trials to see if the drug could potentially be used to help treat people with Atherosclerosis. Separate trials are already underway to use the drug in diabetes and cancer care.